Premium
Successful bone marrow transplantation for life threatening xanthogranuloma disseminatum in neurofibromatosis type‐1
Author(s) -
Savaşan Süreyya,
Smith Laurie,
Scheer Carolyn,
Dansey Roger,
Abella Esteban
Publication year - 2005
Publication title -
pediatric transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 69
eISSN - 1399-3046
pISSN - 1397-3142
DOI - 10.1111/j.1399-3046.2005.00307.x
Subject(s) - medicine , etoposide , neurofibromatosis , carmustine , surgery , chemotherapy , bone marrow , cytarabine , methotrexate , pathology
A 2‐yr and 9‐month‐old female patient with neurofibromatosis type‐1 presented with hepatomegaly, anemia, thrombocytopenia, and croupy cough and diagnosed with xanthogranuloma disseminatum (XD). She failed chemotherapy consisting of steroids, 6‐mercaptopurine and methotrexate. A partial response to HLH‐94 therapy that included etoposide and cyclosporine A was initially observed. However, she continued to have significant organ dysfunction without further improvement at 6 months of therapy. She then received matched unrelated donor bone marrow transplantation (BMT) following carmustine, etoposide, cytarabine and melphelan conditioning with complete resolution of symptoms. BMT is an option in therapy‐resistant, life threatening XD cases.